Mechanism for control of HIV-1 by cytotoxic T lymphocyte
Project/Area Number |
17K10021
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Infectious disease medicine
|
Research Institution | Kumamoto University |
Principal Investigator |
Murakoshi Hayato 熊本大学, ヒトレトロウイルス学共同研究センター, 特任准教授 (60646123)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 細胞傷害性T細胞 / HLA / HIV-1 / CTL |
Outline of Final Research Achievements |
In recent T-cell AIDS vaccine trials, the vaccines did not prevent HIV-1 infection, although HIV-1-specific T cells were induced in the vaccinated individuals, suggesting that the T cells have a weak ability to suppress HIV-1 replication and fail to recognize circulating HIV-1. We previously demonstrated that the T-cell responses to 10 epitopes were significantly associated with good clinical outcome. However, there is no direct evidence that these T cells have strong abilities to suppress HIV-1 replication and recognize circulating HIV-1. Here, we demonstrated that the T cells specific for the 10 epitopes had strong abilities to suppress HIV-1 replication in vitro Moreover, the T cells cross-recognized most of the circulating HIV-1 in HIV-1-infected individuals. This study suggests the use of T cells specific for these 10 epitopes in clinical trials of T-cell vaccines as HIV-1 cure.
|
Academic Significance and Societal Importance of the Research Achievements |
白人や黒人の感染者におけるHLA-B*27/-B*57拘束性T細胞によるHIV-1増殖抑制機構はすでに明らかとなっているが、これらのHLAは日本人を含むアジアではほとんど見られないため、日本人感染者でのT細胞によるHIV-1増殖抑制機構はまだ明らかとなっていない。したがって、日本人HIV-1感染者において、HIV-1増殖抑制に関与しているT細胞の機能解析を行うことは、日本人感染者でのT細胞によるHIV-1増殖抑制機構が明らかとなり、日本人だけでなくアジア人を対象としたHIV-1予防・治療ワクチンの開発に大いに役立つものと考えられる。
|
Report
(4 results)
Research Products
(26 results)
-
[Journal Article] Contribution of Proteasome-Catalyzed Peptide cis-splicing to Viral Targeting by CD8 + T Cells in HIV-1 Infection2019
Author(s)
Paes W, Leonov G, Partridge T, Chikata T, Murakoshi H, Frangou A, Brackenridge S, Nicastri A, Smith AG, Learn GH , Li Y, Parker R, Oka S, Pellegrino P, Williams I, Haynes BF, McMichael AJ, Shaw GM, Hahn BH, Takiguchi M, Ternette N, Borrow P
-
Journal Title
Proceedings of the National Academy of Sciences of the United States of America
Volume: 116
Issue: 49
Pages: 24748-24759
DOI
Related Report
Peer Reviewed
-
[Journal Article] Identification of immunodominant HIV-1 epitopes presented by HLA-C*12:02, a protective allele, using an immunopeptidomics approach2019
Author(s)
Chikata T, Paes W, Akahoshi T, Partridge T, Murakoshi H, Gatanaga H, Ternette N, Oka S, Borrow P, Takiguchi M
-
Journal Title
Journal of Virology
Volume: 93
Issue: 17
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Journal Article] Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines2017
Author(s)
Nicola Borthwick, Zhansong Lin, Tomohiro Akahoshi, Anuska Llano, Sandra Silva-Arrieta, Tina Ahmed, Lucy Dorrell, Christian Brander, Hayato Murakoshi, Masafumi Takiguchi, Tomas Hanke
-
Journal Title
PLoS One
Volume: 12
Issue: 4
Pages: e0176418-e0176418
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Impact of a single escape mutation selected by HLA-A*24:02-restricted CD8+ T cells on HIV-1 control by HLA-B*35:01-restricted ones and T cell adaptation2017
Author(s)
Hayato Murakoshi, Tomohiro Akahoshi, Madoka Koyanagi, Takayuki Chikata, Katherine L James, Yoshiko Tamura, Nozomi Kuse, Xiaoming Sun, Hiroyuki Gatanaga, Sarah L Rowland-Jones, Shinichi Oka, and Masafumi Takiguchi
Organizer
IAS 2017
Related Report
Int'l Joint Research
-
-
-